These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 25800975)

  • 21. The role of new targeted therapies in small-cell lung cancer.
    Rossi A; Maione P; Colantuoni G; Guerriero C; Gridelli C
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):45-53. PubMed ID: 15207253
    [TBL] [Abstract][Full Text] [Related]  

  • 22. SCLC-State of the Art and What Does the Future Have in Store?
    Kahnert K; Kauffmann-Guerrero D; Huber RM
    Clin Lung Cancer; 2016 Sep; 17(5):325-333. PubMed ID: 27397481
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Emerging drugs for small cell lung cancer--an update.
    Metro G; Duranti S; Fischer MJ; Cappuzzo F; Crinò L
    Expert Opin Emerg Drugs; 2012 Mar; 17(1):31-6. PubMed ID: 22288522
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting the MET gene for the treatment of non-small-cell lung cancer.
    Gelsomino F; Facchinetti F; Haspinger ER; Garassino MC; Trusolino L; De Braud F; Tiseo M
    Crit Rev Oncol Hematol; 2014 Feb; 89(2):284-99. PubMed ID: 24355409
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Co-expression network analysis identifies Spleen Tyrosine Kinase (SYK) as a candidate oncogenic driver in a subset of small-cell lung cancer.
    Udyavar AR; Hoeksema MD; Clark JE; Zou Y; Tang Z; Li Z; Li M; Chen H; Statnikov A; Shyr Y; Liebler DC; Field J; Eisenberg R; Estrada L; Massion PP; Quaranta V
    BMC Syst Biol; 2013; 7 Suppl 5(Suppl 5):S1. PubMed ID: 24564859
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ERCC1 and small cell lung cancer.
    Rossi G; Nannini N; Tiseo M
    J Thorac Oncol; 2010 Nov; 5(11):1876-7. PubMed ID: 20975385
    [No Abstract]   [Full Text] [Related]  

  • 27. Second-line treatments of small-cell lung cancers.
    Baize N; Monnet I; Greillier L; Quere G; Kerjouan M; Janicot H; Vergnenegre A; Auliac JB; Chouaid C
    Expert Rev Anticancer Ther; 2017 Nov; 17(11):1033-1043. PubMed ID: 28849951
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Small cell lung cancer: will recent progress lead to improved outcomes?
    Pietanza MC; Byers LA; Minna JD; Rudin CM
    Clin Cancer Res; 2015 May; 21(10):2244-55. PubMed ID: 25979931
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Oncogenic mutation of PIK3CA in small cell lung carcinoma: a potential therapeutic target pathway for chemotherapy-resistant lung cancer.
    Shibata T; Kokubu A; Tsuta K; Hirohashi S
    Cancer Lett; 2009 Oct; 283(2):203-11. PubMed ID: 19394761
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Responses to targeted therapies: lung cancer].
    Brambilla E
    Ann Pathol; 2009 Nov; 29 Spec No 1():S77-80. PubMed ID: 19887261
    [No Abstract]   [Full Text] [Related]  

  • 31. Targeting apoptosis pathways in lung cancer.
    Pore MM; Hiltermann TJ; Kruyt FA
    Cancer Lett; 2013 May; 332(2):359-68. PubMed ID: 20974517
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development of molecularly targeted agents and immunotherapies in small cell lung cancer.
    Sharp A; Bhosle J; Abdelraouf F; Popat S; O'Brien M; Yap TA
    Eur J Cancer; 2016 Jun; 60():26-39. PubMed ID: 27060747
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bromodomain Protein-directed Agents and MYC in Small Cell Lung Cancer.
    Hamilton G; Stickler S; Rath B
    Curr Cancer Drug Targets; 2024; 24(9):930-940. PubMed ID: 38275056
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Other thoracic cancers. Small-cell lung cancer: an update].
    Vermaelen K; van Meerbeeck JP
    Rev Mal Respir; 2008 Oct; 25(8 Pt 2):3S173-82. PubMed ID: 18971843
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Emerging drugs for small-cell lung cancer.
    Metro G; Cappuzzo F
    Expert Opin Emerg Drugs; 2009 Dec; 14(4):591-606. PubMed ID: 19694501
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Involvement of intermediate filament nestin in cell growth of small-cell lung cancer.
    Takakuwa O; Maeno K; Kunii E; Ozasa H; Hijikata H; Uemura T; Kasai D; Ohkubo H; Miyazaki M; Oguri T; Niimi A
    Lung Cancer; 2013 Aug; 81(2):174-9. PubMed ID: 23706418
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Update on new drugs in small cell lung cancer.
    Horn L; Castellanos EL; Johnson DH
    Expert Opin Investig Drugs; 2011 Apr; 20(4):441-5. PubMed ID: 21395484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No Advantage in Survival With Targeted Therapies as Maintenance in Patients With Limited and Extensive-Stage Small Cell Lung Cancer: A Literature-Based Meta-Analysis of Randomized Trials.
    Roviello G; Zanotti L; Cappelletti MR; Gobbi A; Senti C; Bottini A; Generali D
    Clin Lung Cancer; 2016 Sep; 17(5):334-340. PubMed ID: 27346522
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunotherapy for small-cell lung cancer: emerging evidence.
    Reck M; Heigener D; Reinmuth N
    Future Oncol; 2016 Apr; 12(7):931-43. PubMed ID: 26882955
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Advances in Small-Cell Lung Cancer (SCLC) Translational Research.
    Drapkin BJ; Rudin CM
    Cold Spring Harb Perspect Med; 2021 Apr; 11(4):. PubMed ID: 32513672
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.